• Contact
  • Join
  • Log In
  • Profile
Canadian Centre for Applied Research in Cancer Control
  • Home
  • About
    • Our Team
    • Funding & Partners
    • FAQ
    • Contact Us
  • Research Areas
    • Research Projects
      • CanREValue Home
    • Health Technology Assessment
    • Health Systems, Services, and Policy
    • Societal Values and Public Engagement
    • Survivorship
    • Knowledge Translation
  • News
    • News
    • Funding
    • Jobs/Opportunities
  • Events
    • ARCC Conferences
      • ARCC Conference 2023 – #ARCC2023
      • ARCC Conference 2022 – #ARCC2022
      • ARCC Conference 2021 – #ARCC2021
      • ARCC Conference 2020
      • ARCC Conference 2019
        • Conference Presentations 2019
      • ARCC Conference 2018
        • Conference Presentations 2018
      • ARCC Conference 2017
        • Conference Presentations 2017
      • ARCC Conference 2016
        • Conference Presentations 2016
      • ARCC Conference 2015
        • Conference Presentations 2015
      • ARCC Conference 2014
        • Conference Presentations 2014
      • ARCC Conference 2013
        • Conference Presentations 2013
      • ARCC Conference 2012
        • Conference Presentations 2012
  • ARCC Network
    • Membership List
    • Capacity Building
    • Submission
    • Resources
      • Other Presentations
      • Conference Presentations
        • 2019 Conference Presentations
        • 2018 Conference Presentations
        • 2017 Conference Presentations
        • 2016 Conference Presentations
        • 2015 Conference Presentations
        • 2014 Conference Presentations
        • 2013 Conference Presentations
        • 2012 Conference Presentations
    • Links
  • Search
  • Menu
  • CanREValue Home
  • About Us
    • Our Team
  • Working Groups
    • Planning and Drug Selection Working Group
    • Reassessment & Uptake Working Group
    • Methods Working Group
    • Data Working Group
    • Engagement Working Group
  • Knowledge Translation
  • Resources

Planning & Drug Selection Working Group

Scott Gavura

Chair: Scott Gavura (Director, Provincial Drug Reimbursement Programs, Cancer Care Ontario)

The Planning and Drug Selection Working Group was established to develop criteria to identify potential drug indication candidates and select high-priority study questions for real world evaluation. The focus of the Planning and Drug Selection Working Group is on identifying uncertainties at the time of drug funding that may be resolvable through the generation of RWE, along with considerations that should be factored into priority-setting among a basket of drug candidates. In addition, this Group will provide recommendations on potential infrastructure for conducting RWE studies.

Members

Tarry Ahuja (CADTH)

Helen Anderson (BC Cancer)

Helen Anderson (BC Cancer)

Nevzeta Bosnic (PMPRB)

Sylvie Bouchard (INESSS)

Michele de Guise (INESSS)

Melissa Hunt (Health Canada)

Melissa Hunt (Health Canada)

Don Husereau

Don Husereau (IHE)

Gayatri Jayaraman (Health Canada)

Barry Jones (Health Canada)

Elena Lungu (PMPRB)

Valerie McDonald (Patient Representative)

Gunita Mitera (CAPCA)

Rohini Naipaul (Ontario Health)

Stuart Peacock (BC Cancer)

Tanya Potashnik (PMPRB)

Craig Simon (Health Canada)

Marianne Taylor (BC Cancer)

Maureen Trudeau (Sunnybrook Research Institute)

Maureen Trudeau (Sunnybrook Research Institute)

Alicia Wall (Eastern Health)

Danica Wasney (CancerCare Manitoba)

Danica Wasney (CancerCare Manitoba)

Angie Wong (MOHLTC)

Do you have any questions, comments, or suggestions regarding the content of this page? If so, please contact us at CanREValue@cc-arcc.ca 

Recent Projects

  • The Canadian Centre for Applied Research in Cancer ControlPatient perspectives of Value Frameworks used to Guide Oncology Treatment DecisionsMay 1, 2021 - 12:27 pm
  • The Canadian Centre for Applied Research in Cancer ControlUnderstanding British Columbia cancer patients’ experiences with virtual health before and during the COVID-19 pandemicMay 1, 2021 - 11:53 am
  • The Canadian Centre for Applied Research in Cancer ControlBenchmarking End of Life Quality Indicators by Tumor Type & Describing models of palliative care across CanadaApril 1, 2021 - 8:56 am
  • The Canadian Centre for Applied Research in Cancer ControlEvaluation of the systemic cancer therapy volume-outcome association: a population-based study to inform the optimal provincial organization and delivery of systemic cancer therapyFebruary 1, 2021 - 12:20 pm

RECENT POSTS

  • CAHSPR is seeking the 2023 Article of the YearFebruary 1, 2023 - 7:41 am
  • CADTH Recognition Awards – Nominations Now Open!January 27, 2023 - 2:55 pm
  • Help establish research priorities for AYA Cancer in CanadaJanuary 27, 2023 - 7:36 am
  • BioCanRx – Summer Studentship – Call for ApplicationsJanuary 13, 2023 - 11:48 am

Login Status

Forgot?  Register
© Copyright 2021 - Canadian Centre for Applied Research in Cancer Control - Website by North Studio
Scroll to top
Translate »